WHAT IS TruDOSE™?

---

List of conditions providers are treating using TruDose include:

• Adult Autism
• Vertigo/ Vestibular balance
• Memory issues
• Hashimotos
• Kidney Failure
• Academic Improvement
• Psychosis, schizophrenia
• Foot Drop
• Various chronic pain for musculoskeletal conditions
• Liver failure
• Vision
• POTS
• COVID Long haulers (hair loss, sensation loss, sensory loss)
• PANS / PANDAS
• Migraines, TBI, Concussion, Migraines
• LUPUS
• Food sensitivities
• Viral antibodies
• Urinary Incontinence (sneeze and pee), Interstitial Cystitis
• End-stage Liver disease
• Lichen planopilaris and other hair loss
• Shingles
• Insulin resistance
• Parkinson's, MS, ALS
• GERD
• LYME
• Yeast
• Candida overload
• Neuropathy
• Post Covid vaccination injury

Platelets are continually circulating the bloodstream actively overseeing the two most important activities of your body, your repair system and immune system. When a specific amount of blood is removed from your body and reintroduced at the right amount (dose/ concentration) meant for you at that specific time, three things happen:

1. Your immune and repair system is reset.
2. Excess platelets restart old, unresolved inflammatory repair and immune issues that are stuck in negative feedback loops so they can continue to complete their individual cycle of repair or immune clearance.
3. The ideal concentration amount (dose/concentration) recalibrates the ratios of various cells circulating in the bloodstream.

After completing your complimentary consultation and it is determined you may be a good fit, you will schedule your treatment appointment. Treatments are done in our office on Saturdays. Here is what to expect during your treatment:

1. Finger prick to test your blood. (1 min)

2. Blood is measured and software is used for your personalized treatment. (5 min)

3. Blood is drawn based on your personalized treatment and centrifuged to separate the platelets. (20 min)

4. After centrifugation, treatment is remeasured to confirm platelet concentration amount. (5 min)

5. Following confirmation, treatment is administered. (10 min)

6. Observation: Your provider will observe you for a short period of time. (10 min)

7. Start to finish the treatment time is approximately  60 - 120 minutes. Times vary by patient and observation may be extended. 

TruDOSE Regenerative Therapy™ is considered a very low risk procedure. It is an autologous procedure – meaning it is using blood from your own body. Some patients may experience a temporary herxheimer reaction following the treatment. Speak to your TruDOSE™ provider on ways to minimize or eliminate herxheimer reactions. 

Treatment success varies from patient to patient. Depending on your condition, you may need more treatments. 

Like most treatments, there is ALWAYS a possibility you will not see the results you anticipate. 

The cost is $1500 per treatment. A $750 non refundable deposit is due when scheduling your treatment. The remainder $750 is due at the time of your treatment. The amount of treatments needed vary by patient. 

Please visit https://www.trudose.com/ to learn more about TruDose!

This web site is provided for educational and informational purposes about platelet therapy and does not constitute providing medical advice or professional services. All information provided on this website is from physician observational evidence or patient testimonials and not published clinical studies or clinical trials. As such, this information should not be used for diagnosing or treating a health problem or disease.  Individuals seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. No physician-patient relationship is created by this web site or its use.

​

As of June 1, 2021, the FDA updated their guidance on all “stem cell regenerative” therapies. The FDA makes a clear distinction on the use of autologous (from you) platelet therapies compared to donor cell therapies (cells not from you). The FDA1 states: “This guidance also does not apply to products that fall outside the definition of HCT/P in 21 CFR 1271.3(d). For example, platelet rich plasma (PRP, blood taken from an individual and given back to the same individual as platelet rich plasma) is not an HCT/P under 21 CFR Part 1271 because it is a blood product. Accordingly, FDA does not apply the criteria in 21 CFR 1271.10(a) to PRP, and PRP is outside the scope of this guidance.”

​

https://www.fda.gov/media/109176/download